Nmc Biopharm Limited - Company Profile

It is a pharma public limited company based in Delhi, Delhi, India, established in 2002.
2002 Delhi, Delhi, India Active
Last Updated:
Access Report
About Nmc Biopharm Limited

Nmc Biopharm Limited, a active public limited company, was established on 11 February 2002 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24231DL2002PLC114170. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹14.00 Cr.

Formerly known as Nmc Overseas Private Limited, Nmc Biopharm Private Limited. It upholds a active non-compliant status. Its leadership includes Ananjan Chaudhri (Additional Director), Naveen Chaudhri (Managing Director), Amita Chaudhri (Additional Director). Past directors included Vipal Kumar Kalra, Vinod Bhargava, Shashi Sinha. It holds ₹21.70 Cr open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at E-485, 2Nd Floor,Near Old Police Station Opposite Punit Apartment,New Ashok Nagar, Delhi, Delhi, 110096.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231DL2002PLC114170

  • Registration Number

    114170

  • Incorporation Date

    11 February 2002

  • Authorized Capital

    ₹15.00 Cr

  • Paid-Up Capital

    ₹14.00 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 14.00 Cr
  • Company Age 23 Year, 11 Months
  • Last Filing with ROC 31 Mar 2021
  • Open Charges ₹ 21.70 Cr
  • Revenue Growth **** %
  • Profit Growth **** 27.19%
  • Ebitda **** 78.20%
  • Net Worth -48.02%
  • Total Assets -3.47%
Company report

Nmc Biopharm Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nmc Biopharm Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Nmc Biopharm Limited?
Current Directors
Name Designation Appointment Date Status
Ananjan Chaudhri Additional Director 02 Apr 2018 Current
Naveen Chaudhri Managing Director 11 Feb 2002 Current
Amita Chaudhri Additional Director 14 Aug 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Dec 2008 Past
Pramod Abcsdd Additional Director 14 Aug 2017 Past
Pramod Abcsdd Company Secretary 17 Aug 2015 Past
Pramod Abcsdd Additional Director 06 Jun 2015 Past
Pramod Abcsdd Director 02 Apr 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nmc Biopharm.

Nmc Biopharm Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 27.19% increase in profit. The company's net worth observed a substantial decline by a decrease of 48.02%.

Nmc Biopharm revenue growth over time
Nmc Biopharm profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -3.47%
*******
*******
*******
*******
Profit or Loss
*******
 27.19%
*******
*******
*******
*******
Net Worth
*******
 -48.02%
*******
*******
*******
*******
EBITDA
*******
 78.20%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nmc Biopharm?

In 2021, Nmc Biopharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹217,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Dhanlaxmi Bank Limited : 20.00 Cr
  • Vijaya Bank : 1.00 Cr
  • The Delhi Safe Depostis Company Limited : 0.70 Cr
Latest Charge Details
Date Lender Amount Status
24 Dec 2014 The Delhi Safe Depostis Company Limited ₹7.00 M Open
23 Apr 2012 Dhanlaxmi Bank Limited ₹20.00 Cr Open
27 Aug 2002 Vijaya Bank ₹5.00 M Open
27 Aug 2002 Vijaya Bank ₹5.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Nmc Biopharm?

Unlock and access historical data on people associated with Nmc Biopharm, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nmc Biopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nmc Biopharm's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nmc Biopharm
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Nmc Biopharm Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.

  • Balance Sheet

    Nmc Biopharm Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Ananjan Chaudhri was appointed as a Additional Director was appointed as a Additional Director on 02 Apr 2018 & has been associated with this company since 7 years 10 months . was documented.

  • Director Appointment

    Progress on Amita Chaudhri was appointed as a Additional Director was appointed as a Additional Director on 14 Aug 2017 & has been associated with this company since 8 years 5 months . was documented.

  • Charges

    The activity A charge with The Delhi Safe Depostis Company Limited amounted to Rs. 0.70 Cr with Charge ID 10543396 was registered on 24 Dec 2014. was completed.

  • Charges

    The activity A charge with Dhanlaxmi Bank Limited amounted to Rs. 20.00 Cr with Charge ID 10351041 was registered on 23 Apr 2012. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nmc Biopharm Limited?

The CIN of Nmc Biopharm Limited is U24231DL2002PLC114170.

Where is Nmc Biopharm Limited headquartered?

Nmc Biopharm Limited is headquartered at E-485, 2Nd Floor,Near Old Police Station Opposite Punit Apartment,New Ashok Nagar, Delhi, Delhi, 110096.

When was Nmc Biopharm Limited incorporated?

Nmc Biopharm Limited was incorporated on 11 February 2002.

Who are the current directors of Nmc Biopharm Limited?

The current directors of Nmc Biopharm Limited are

What is the primary industry of Nmc Biopharm Limited?

The primary industry of Nmc Biopharm Limited is Pharma.

Is Nmc Biopharm Limited a listed company?

Nmc Biopharm Limited is unlisted.

What is the capital structure of Nmc Biopharm Limited?

The authorized capital of Nmc Biopharm Limited is ₹15.00 Cr, and the paid-up capital is ₹14.00 Cr.

What is the compliance status of Nmc Biopharm Limited?

The compliance status of Nmc Biopharm Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available